Suppr超能文献

可溶性 Trem2 通过 CD36 受体再循环的方式成为脑出血后红细胞吞噬的负调控因子。

Soluble Trem2 is a negative regulator of erythrophagocytosis after intracerebral hemorrhage in a CD36 receptor recycling manner.

机构信息

Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Jiefang Road88th, Hangzhou 310016, People's Republic of China.

Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Jiefang Road88th, Hangzhou 310016, People's Republic of China.

出版信息

J Adv Res. 2023 Feb;44:185-199. doi: 10.1016/j.jare.2022.03.011. Epub 2022 Mar 18.

Abstract

INTRODUCTION

Microglia and macrophages participate in hematoma clearance after intracerebral hemorrhage (ICH), thereby facilitating tissue restoration and neurological recovery. Triggering receptor expressed on myeloid cells 2 (Trem2) has been indicated as a major pathology-induced immune signaling hub on the microglial/macrophage surface. Soluble Trem2 (sTrem2), the proteolytic form of Trem2, is abundant in the body fluid and is positively correlated with the pathological process.

OBJECTIVES

In the present study, we aimed to investigate the potential role of sTrem2 in hematoma resolution after ICH and to elucidate its underlying mechanisms.

METHODS

We explored the biological functions of sTrem2 in the murine ICH brain by stereotaxic injection of recombinant sTrem2 protein or by adeno-associated virus-mediated expression. Erythrocyte phagocytosis was assessed using flow cytometry and immunofluorescence. Western blotting was performed to evaluate protein expression. Changes in behavior, sTrem2-induced down-stream pathway, and microglia were examined.

RESULTS

sTrem2 impedes hematoma resolution and impairs functional motor and sensory recovery. Interestingly, sTrem2 bypasses full-length Trem2, negatively regulating microglial/macrophage erythrophagocytosis, and promotes an inflammatory phenotype, which is associated with reduced retromer levels and impaired recycling of the pro-erythrophagocytic receptor CD36. Rescue of retromer Vps35 abolishes the phagocytosis-inhibiting effects and lysosome-dependent CD36 degradation caused by sTrem2.

CONCLUSION

These findings indicate sTrem2 as a negative factor against microglia/macrophage-mediated hematoma and related neuronal damage clearance, provide insight into the mechanisms by which erythrophagocytosis is regulated and how it may be impaired after ICH, and suggest that the anti-proteolytic activity of Trem2 can be explored for ICH therapy.

摘要

简介

小胶质细胞和巨噬细胞参与脑出血(ICH)后的血肿清除,从而促进组织修复和神经功能恢复。髓样细胞触发受体 2(Trem2)已被确定为小胶质细胞/巨噬细胞表面主要的病理诱导免疫信号枢纽。可溶性 Trem2(sTrem2)是 Trem2 的蛋白水解形式,在体液中含量丰富,与病理过程呈正相关。

目的

本研究旨在探讨 sTrem2 在 ICH 后血肿溶解中的潜在作用,并阐明其潜在机制。

方法

我们通过立体定向注射重组 sTrem2 蛋白或腺相关病毒介导的表达,探索了 sTrem2 在小鼠 ICH 大脑中的生物学功能。使用流式细胞术和免疫荧光法评估红细胞吞噬作用。通过 Western blot 评估蛋白表达。检测行为变化、sTrem2 诱导的下游通路和小胶质细胞。

结果

sTrem2 阻碍血肿溶解,损害运动和感觉功能的恢复。有趣的是,sTrem2 绕过全长 Trem2,负调控小胶质细胞/巨噬细胞红细胞吞噬作用,并促进炎症表型,与 retromer 水平降低和促红细胞吞噬受体 CD36 的回收受损有关。retromer Vps35 的拯救消除了 sTrem2 引起的吞噬抑制作用和溶酶体依赖性 CD36 降解。

结论

这些发现表明 sTrem2 是一种对抗小胶质细胞/巨噬细胞介导的血肿和相关神经元损伤清除的负性因素,深入了解了红细胞吞噬作用的调节机制以及 ICH 后如何受损,并表明 Trem2 的抗蛋白水解活性可用于 ICH 治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcd4/9936424/c61f96dcd5d1/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验